Pharmaceutical

Lexicon partners Viatris for global expansion of sotagliflozin

Lexicon Pharmaceuticals has entered a licensing agreement with Viatris to commercialise sotagliflozin outside the US and Europe.

Oct 18, 2024 - 04:00
Lexicon partners Viatris for global expansion of sotagliflozin
Lexicon Pharmaceuticals has entered a licensing agreement with Viatris to commercialise sotagliflozin outside the US and Europe.
Read the original article

Tags:

Previous Article

Health Canada approves Acadia’s DAYBUE for Rett syndrome

Next Article

J&J trims neuroscience pipeline – seltorexant in Alzheimer’s disease dropped 

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Diakonos’ brain tumour vaccine wins FDA’s orphan drug designation

Diakonos’ brain tumour vaccine wins FDA’s orphan drug d...

Jan 3, 2024

Bayer’s new CEO was dealt a duo of ‘clearing events.’ Tough choices lie ahead

Bayer’s new CEO was dealt a duo of ‘clearing events.’ T...

Nov 21, 2023

Early AMR pipeline looks beyond traditional antibiotics

Early AMR pipeline looks beyond traditional antibiotics

Mar 22, 2024